Home
About
Overview
Sharing Data
ORCID
Help
History (52)
Aldosterone excess and cardiorenal risk: more common than appreciated.
A global action agenda for turning the tide on fatty liver disease.
Phase II study of the histone deacetylase inhibitor Romidepsin in relapsed small cell lung cancer (Cancer and Leukemia Group B 30304).
Radiation-inducible gene therapy.
The double challenge of resistant hypertension and chronic kidney disease.
See All 52 Pages
Find People
Find Everything
Login
to edit your profile (add a photo, awards, links to other websites, etc.)
Edit My Profile
My Person List (
0
)
Return to Top
The double challenge of resistant hypertension and chronic kidney disease.
The double challenge of resistant hypertension and chronic kidney disease. Lancet. 2015 Oct 17; 386(10003):1588-98.
View in:
PubMed
subject areas
Antihypertensive Agents
Blood Pressure
Diet, Sodium-Restricted
Diuretics
Humans
Hypertension
Renal Insufficiency, Chronic
Risk Factors
Treatment Outcome